Synthesis and antiviral activity of several 2,5'-anhydro analogues of 3'-azido-3'-deoxythymidine, 3'-azido-2',3'-dideoxyuridine, 3'-azido-2',3'-dideoxy-5-halouridines, and 3'-deoxythymidine against human immunodeficiency virus and Rauscher-murine leukemia

Synthesis and antiviral activity of several 2,5'-anhydro analogues of 3'-azido-3'-deoxythymidine, 3'-azido-2',3'-dideoxyuridine, 3'-azido-2',3'-dideoxy-5-halouridines, and 3'-deoxythymidine against human immunodeficiency virus and Rauscher-murine leukemia
复制标题

3-叠氮基-3-脱氧胸苷、3-叠氮基-2,3-二脱氧尿苷、3-叠氮基-2,3-二脱氧-的几种2,5-脱水类似物的合成和抗病毒活性

DOI:
10.1021/jm00128a034
复制
发表时间:
1989
影响因子:
7.3
通讯作者:
Prusoff,WH
Prusoff,WH
中科院分区:
医学1区
文献类型:
--
作者:
Lin,TS;Shen,ZY;August,EM;Brankovan,V;Yang,H;Ghazzouli,I;Prusoff,WH

文献摘要

参考文献

相似文献

3 ′-叠氮基-3 ′-脱氧胸苷(AZT)、3 ′-叠氮基-2 ′,3 ′-双脱氧尿苷(AZU)、3 ′-叠氮基-2 ′,3 ′-双脱氧-5-溴尿苷、3 ′-叠氮基-2 ′,3 ′-双脱氧-5-碘尿苷的几种2,5 ′-脱水类似物,3 ′-脱氧胸苷和5-甲基-2 ′-脱氧异胞苷的3 ′-叠氮衍生物已被合成,以评价其潜在的抗HIV活性(人类免疫缺陷病毒)剂。这些2,5 '-脱水衍生物,化合物13-17,表现出显著的抗HIV-1活性,IC 50值分别为0.56、4.95、26.5、27.1和48 µ。与母体化合物AZT和AZU相比,相应的2,5 '-脱水类似物,化合物13和14,活性稍低。AZT具有细胞毒性,其TCID 60为29 µ,而AZT的2,5 '-脱水衍生物化合物13的毒性则大大降低,其TCID 50值> 100 µ。5-甲基-2H-脱氧异胞苷的2,5 '-脱水类似物也显示出抗HIV-1活性,IC 60值为12 µ。还在细胞培养物中评价了这些化合物对Rauscher-鼠白血病病毒(R-MuLV)的作用。其中,AZT、3 '-叠氮基-2',3 '-双脱氧-5-碘尿苷、3'-叠氮基-2 ',3'-双脱氧-5-溴尿苷和2,5 '-脱水-3'-叠氮基-3 '-脱氧胸苷(13)的活性最高,IC 50值分别为0.023、0.21、0.23和0.27 µ。齐多夫定(AZT,Zidovudine)首先由Horwitz等人2合成,后来由Lin和Prusoff修改了该方法。3 3 ′-叠氮基-2 ′,3 ′-双脱氧尿苷(2,AZU)首先由Lin 4合成,随后Schinazi等5报道AZU(CS-87)具有显著的抗HIV活性。Lin等人6和Hirsch提到了AZT的许多生物化学和临床研究。7据报道,AZT在治疗
Several 2, 5'-anhydro analogues of 3'-azido-3'-deoxythymidine (AZT), 3'-azido-2', 3'-dideoxyuridine (AZU), 3'-azido-2', 3'-dideoxy-5-bromouridine, 3'-azido-2', 3'-dideoxy-5-iodouridine, and 3'-deoxythymidine and the 3'-azido derivative of 5-methyl-2'-deoxyisocytidine have been synthesized for evaluation as potential anti-HIV (human immunodeficiency virus) agents. These 2, 5'-anhydroderivatives, compounds 13-17, demonstrated significant anti-HIV-1activity with IC50 values of 0.56, 4.95, 26.5, 27.1, and 48 µ, respectively. Compared to that of the parent compounds AZT and AZU, the respective 2, 5'-anhydro analogues, compounds 13 and 14, were somewhat less active. Whereas AZT was cytotoxic with a TCID60 of 29 µ, the toxicity of the 2, 5'-anhydro derivative of AZT, compound 13, was reduced considerably to a TCID50 value of> 100 µ. The 2, 5'-anhydro analogue of 5-methyl-2/-deoxyisocytidine also demonstrated anti-HIV-1activity with an IC60 value of 12 µ. These compounds were also evaluated against Rauscher-Murine leukemia virus (R-MuLV) in cell culture. Among them, AZT, 3'-azido-2', 3'-dideoxy-5-iodouridine, 3'-azido-2', 3'-dideoxy-5-bromouridine, and 2, 5'-anhydro-3'-azido-3'-deoxythymidine (13) were found to be most active, with IC50 values of 0.023, 0.21, 0.23, and 0.27 µ, respectively.3'-Azido-3'-deoxythymidine (AZT, Zidovudine) was first synthesized by Horwitz et al. 2 and later by a modification of this procedure by Lin and Prusoff. 3 3'-Azido-2', 3'-dideoxyuridine (2, AZU) was first synthesized by Lin4 and, subsequently, Schinazi et al. 5 reported that AZU (CS-87) possesses significant anti-HIV activity. References to many biochemical and clinical studies of AZT have been presented by Lin et al. 6 and Hirsch. 7 AZT has been reported to be of marked benefit in the
Tuftsin:一种激素样四肽,具有抗菌和抗肿瘤活性。
DOI: 10.1016/0024-3205(81)90684-6
发表时间: 1981
期刊: Life sciences
影响因子: 6.1
作者:
Nishioka,K;Amoscato,AA;Babcock,GF
通讯作者: Babcock,GF
吞噬作用刺激肽 tuftsin 在人多形核白细胞和单核细胞上的特异性结合位点。
DOI: 10.1016/0006-291x(78)91032-x
发表时间: 1978
影响因子: 3.1
作者:
Y. Stabinsky;P. Gottlieb;V. Zakuth;Z. Spirer;M. Fridkin
通讯作者: M. Fridkin
Tuftsin 和其他蛋白质中类似序列的功能
DOI: 10.1111/j.1749-6632.1983.tb37102.x
发表时间: 1983
影响因子: 5.2
作者:
S. Segal;E. Tzehoval;M. Feldman
通讯作者: M. Feldman
DOI: 10.1016/s0021-9673(00)81826-9
发表时间: 1981
期刊: Journal of chromatography
影响因子: --
作者:
Amoscato,AA;Babcock,GF;Nishioka,K
通讯作者: Nishioka,K
放射性标记的促吞噬素与人中性粒细胞的相互作用。
DOI: 10.1016/0161-5890(78)90125-6
发表时间: 1978
期刊: Immunochemistry
影响因子: --
作者:
Raghavan M.G. Nair;Raghavan M.G. Nair;Bruce E Ponce;H. Fudenberg
通讯作者: H. Fudenberg